Skip to content

A Multicentre Observational Study to Evaluate Clinical Outcomes of the G7 Acetabular System

A Multicentre Observational Study to Evaluate Clinical Outcomes of the G7 Acetabular System - G7 Early evaluators

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON50332
Enrollment
21
Registered
2014-06-30
Start date
2014-09-09
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Arthrosis Hip Wear

Interventions

The use of a G7 cup in total hip replacement.

Sponsors

Biomet GSCC B.V.
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Selection of subjects for this evaluation should be in accordance with the indications of the G7 cup specifically: Subjects with one of the following indication: - Noninflammatory degenerative joint disease including osteoarthritis and avascular necrosis. - Rheumatoid arthritis. - Correction of functional deformity. - Treatment of non-union, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement, unmanageable by other techniques. - Revision procedures where other treatment or devices have failed. Additional inclusion criteria include: - Male or female. - 18 years of age or older - Subjects willing to return for follow-up evaluations.

Exclusion criteria

Exclusion criteria: Exclusion criteria should be in accordance with Contraindications for the G7 cup. Absolute contraindications include: infection, sepsis and osteomyelitis, Additional contraindications include: - Subjects unable to cooperate with and complete the study - Dementia and inability to understand and follow instructions - Neurological conditions affecting movement - Pregnancy

Design outcomes

Primary

MeasureTime frame
Harris Hip Score (HHS) at 2 year postoperative

Secondary

MeasureTime frame
Oxford Hip Score at 1,2,5 year postop Radiographic Evaluation: radiographic outcome, stability, incidence of radiolucencies around the prosthesis and bone remodeling Adverse Events/Complications (including revisions/removals of the study hip). Survivorship

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)